Among individuals across a spectrum of risk for Parkinson disease (PD), cognitive function is worse among those with the characteristic most strongly associated with future risk of PD or dementia with Lewy bodies, namely REM sleep behavior disorder (RBD), a recent study found.
Participants belonging to the following cohorts of the Parkinson Progression Markers Initiative (PPMI) study were included: de novo PD with dopamine transporter binding deficit (n=423), idiopathic RBD (n=39), hyposmia (n=26), and non-PD mutation carrier (NMC; Leucine-rich repeat kinase 2 G2019S [n=88] and glucocerebrosidase [GBA] gene [n=38] mutations). Researchers found:
- The RBD cohort performed significantly worse than the hyposmia and NMC cohorts on Symbol Digit Modality Test and Judgment of Line Orientation.
- The RBD cohort also performed worse than the hyposmia cohort on the Montreal Cognitive Assessment.
- Hyposmics did not differ from PD or NMC cohorts on any cognitive test score.
Chahine LM, Urbe L, Caspell-Garcia C, et al, the Parkinson’s Progression Markers Initiative. Cognition among individuals along a spectrum of increased risk for Parkinson’s disease. [Published online ahead of print August 20, 2018]. PLoS One. doi:10.1371/journal.pone.0201964.
This Week's Must Reads
Must Reads in Movement Disorders
Risk Factors for Suicidality in Huntington Disease, Neurology; ePub 2019 Mar 8; McGarry, et al
Tourette, CTD, and Cardiometabolic Disorders Link, JAMA Neurology; ePub 2018 Jan 14; Brander, et al
Study Compares 2 Cognitive Assessment Tools, Mov Disord; ePub 2018 Dec 10; Hendershott, et al
White Matter Differences Between ET and PD, Neurology; ePub 2018 Nov 30; Juttukonda, et al